A phase 1b study of napabucasin (NAPA) plus weekly paclitaxel (PTX) in patients (pts) with advanced thymoma and thymic carcinoma.

被引：4
|
作者：
Kalra, Maitri
Cote, Gregory Michael
Heist, Rebecca Suk
Spittler, Aaron John
Yu, Song
Hitron, Matthew
Loehrer, Patrick J.
机构：
[1] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Boston Biomed Inc, Boston, MA USA
[4] Boston Biomed Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20578
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20578
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase 1b study of napabucasin plus weekly paclitaxel in patients with advanced thymoma and thymic carcinoma
    Hitron, Matthew
    Spittler, Aaron John
    Cote, Gregory Michael
    Heist, Rebecca Suk
    Kossler, Kimiko
    Li, Wei
    Li, Youzhi
    Li, Chiang
    Loehrer, Patrick J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] A phase Ib study of napabucasin plus weekly paclitaxel in patients with advanced melanoma.
    Edenfield, William Jeffery
    Becerra, Carlos
    Braiteh, Fadi S.
    Spira, Alexander I.
    Sullivan, Ryan J.
    Panella, Timothy J.
    Li, Wei
    Huang, Janet
    Li, Youzhi
    Flaherty, Keith
    Hitron, Matthew
    Li, Chiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] The BRIGHTER trial: A phase 3 randomized double-blind study of napabucasin (NAPA) plus paclitaxel (PTX) versus placebo (PBO) plus PTX in patients (pts) with pretreated advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.
    Shah, Manish A.
    Shitara, Kohei
    Lordick, Florian
    Bang, Yung-Jue
    Tebbutt, Niall C.
    Metges, Jean-Philippe
    Muro, Kei
    Shen, Lin
    Tjulandin, Sergei
    Hays, John L.
    Xu, Rui-hua
    Fontaine, Marilyn
    Brooks, Emily
    Xu, Bo
    Li, Wei
    Li, Chiang
    Borodyansky, Laura
    Van Cutsem, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] A phase 1b/2 study of napabucasin with weekly paclitaxel in advanced, previously treated platinum resistant ovarian cancer.
    Becerra, Carlos
    Garcia, Agustin A.
    Hays, John L.
    Method, Michael W.
    Richey, Stephen Lane
    Langleben, Adrian
    Richards, Donald A.
    Cote, Gregory Michael
    Kossler, Kimiko
    Li, Wei
    Li, Youzhi
    Hitron, Matthew
    Li, Chiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma
    Lemma, Girum L.
    Lee, Ju-Whei
    Aisner, Seena C.
    Langer, Corey J.
    Tester, William J.
    Johnson, David H.
    Loehrer, Patrick J., Sr.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2060 - 2065
  • [6] A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: E1C99
    Lemma, G. L.
    Loehrer, P. J., Sr.
    Lee, J. W.
    Langer, C. J.
    Tester, W. J.
    Johnson, D. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.
    Lee, Sunyoung S.
    Miller, Austin
    Krishnamurthi, Smitha S.
    Estfan, Bassam N.
    Frazer, Andrea
    Wang, Chong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric Cancer
    Shitara, Kohei
    Yodo, Yasuhide
    Iino, Shuichi
    [J]. IN VIVO, 2019, 33 (03): : 933 - 937
  • [9] A phase 1b study of ruxolitinib (Rux) plus gemcitabine (G) ± nab-paclitaxel (N) in patients (pts) with advanced solid tumors.
    Bauer, Todd Michael
    Patel, Manish R.
    Wood, Tina Evans
    George, Thomas J.
    Dawkins, Fitzroy W.
    Brill, Kimberli J.
    Du, Yining
    Hurwitz, Herbert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [10] Phase 1b/2 trial of cancer stemness inhibitor napabucasin (NAPA) plus nab-paclitaxel (nPTX) and gemcitabine (Gem) in metastatic pancreatic adenocarcinoma (mPDAC).
    Bekaii-Saab, Tanios S.
    Starodub, Alexander
    El-Rayes, Bassel F.
    Shahda, Safi
    O'Neil, Bert H.
    Noonan, Anne M.
    Shaib, Walid Labib
    Hanna, Wahid Tewfik
    Mikhail, Sameh
    Neki, Anterpreet S.
    Chang, Yue
    Dai, Xiaoshu
    Li, Wei
    Brooks, Emily
    Oh, Cindy
    Borodyansky, Laura
    Li, Chiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345